Clinical trial Recruiting at 1 site Interventional Ages 1 Hour to 7 Days

Close Collaboration with Parents training to strengthen parent–staff partnership in the NICU

Official title: Effects of Close Collaboration With Parents Intervention on NICU Care Environments and Long-term Development of Preterm Infants: a Pilot Study

Run by Turku University Hospital · NCT07306000 · Data updated 2026-11-12

This pilot tests whether training NICU staff to work closely with parents improves long-term development and parent–infant interaction for very preterm infants.

More Infant Development trials

Quick facts

Study typeInterventional
Ages1 Hour to 7 Days
SexAll
Enrollment100 (estimated)
SponsorTurku University Hospital
Government
Locations3 sites (Matsumoto, Nagano and 2 other locations)
StatusRecruiting
StartedDecember 22, 2025
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedDecember 31, 2025
Trial IDNCT07306000 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are very preterm infants (born before 32 weeks gestation and/or weighing under 1500 g) receiving long-term follow-up at one of the participating NICUs whose parents can consent in Korean or Japanese and whose clinical condition is stable.

Probably not a fit

Infants with major congenital anomalies, triplets or higher-order multiples, those with critical unstable conditions, or families unable to consent in the study languages are unlikely to benefit from this pilot.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot will train multi-professional NICU staff in the Close Collaboration with Parents (CCP) program and use the intervention to refine and validate measurement tools before a larger cluster randomized trial. It is a multicenter feasibility study conducted at participating NICUs in Japan and South Korea enrolling infants born before 32 weeks gestation and/or weighing under 1500 g who attend long-term follow-up. The study will examine feasibility of instruments that measure neurodevelopment, socio-emotional development, and parent–infant interaction and will collect data needed to calculate sample size for the definitive trial. Infants with major anomalies, higher-order multiples, or unstable survival prognoses are excluded, and parents must understand consent in Korean or Japanese.

Why it matters

Potential benefit: If successful, the intervention could increase parental participation in care and lead to better long-term neurodevelopmental and socio-emotional outcomes for very preterm infants.

How similar studies have gone: CCP is an evidence-based staff education approach that has improved parental involvement and short-term NICU processes in previous work, but its effects on long-term neurodevelopmental and socio-emotional outcomes in very preterm infants have not yet been tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* preterm infants born below 32 weeks of gestation and/or weighing \< 1500 g who receive long-term follow-up at each study site.

Exclusion Criteria:

* the infant has any major anomalies
* the infants are triplets or higher order
* the infant's condition is critical and the survival is uncertain
* the parents cannot understand the informed consent form in Korean or in Japanese

Where it's running

  • Korea University Anam Hospital NICU
    Seoul, South Korea
    Recruiting
  • Nagano Children's Hospital
    Matsumoto, Nagano, Japan
    Not yet recruiting
  • Kyoto University Hospital
    Kyoto, Japan
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.